Buscar en
Diálisis y Trasplante
Toda la web
Inicio Diálisis y Trasplante The NT-proBNP: A useful marker of cardiac dysfunction in chronic hemodialysis pa...
Información de la revista
Vol. 36. Núm. 1.
Páginas 40 (Enero - Junio 2015)
Descargar PDF
Más opciones de artículo
Vol. 36. Núm. 1.
Páginas 40 (Enero - Junio 2015)
Letter to the Editor
Acceso a texto completo
The NT-proBNP: A useful marker of cardiac dysfunction in chronic hemodialysis patients
NT-proBNP: un marcador útil de la disfunción cardíaca en pacientes en hemodiálisis crónica
Gioacchino Li Cavolia,
Autor para correspondencia

Corresponding author.
, Silvia Passananteb, Onofrio Schillacia, Carmela Zagarrigoa, Franca Servilloa, Tancredi Vincenzo Li Cavolia, Mattia Palmeria, Ugo Rotoloa
a Nephrology-Dialysis Department, Civico and Di Cristina Hospital, Palermo, Italy
b Clinical Pathology, Civico and Di Cristina Hospital, Palermo, Italy
Información del artículo
Texto completo
Descargar PDF
Texto completo
To Editor:

Brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are useful biomarkers in the management of heart failure, stable coronary artery disease and acute coronary syndrome because of their relevant prognostic information. In patients on chronic hemodialysis treatment (HD) these biomarkers are often elevated due to cardiac dysfunction but in recent years these molecules have been also associated with fluid overload.1,2 We report our experience on this topic. During 24 months we studied 47 outpatients (28M/19F, mean age 69 years, median dialysis vintage 4 years) who attended for thrice weekly standard bicarbonate HD in Palermo, Italy. NT-proBNP was measured by an electrochemiluminescence immunoassay (Elecsys 2010 Roche Diagnostic, analytic range 5–3500pg/ml). During the observation period, blood samples were taken from the inlet blood lines immediately before the onset of dialysis session. We investigated the correlation between NT pro-BNP and cardiovascular diseases. All patients were studied by echocardiography; we detected left ventricular hypertrophy in 72.4% of the subjects with a mean left ventricular ejection fraction of 55%. During the observation period, 18 patients died. In these subjects, the mean value of NT-proBNP was 23,931pg/ml but in the 13 patients who died from cardiovascular causes, the mean value was considerably higher (58,638pg/ml). Analyzing all subjects (alive at the end and died during the observation period) the mean value of NT-proBNP was 7643pg/ml at the beginning and increased to 16,952pg/ml at the end of study period. We consider this trend as the result of multiple elements harmful to the cardiovascular system and not only for impaired renal clearance.

In conclusion, NT-proBNP provides important information on cardiac dysfunction of dialysis patients. This biomarker is also a predictor of cardiovascular mortality in both HD and PD patients. In the family of natriuretic peptides, NT-proBNP seems to be the best predictor of clinical outcome and should be a part of the routine for cardiovascular risk assessment in these subjects.

Conflict of interest

The authors have declared that no conflict of interest exists.

S. Snaedal, A.R. Qureshi, J.J. Carrero, O. Heimbürger, P. Stenvinkel, P. Bárány.
Determinants of N-terminal pro-brain natriuretic peptide variation in hemodialysis patients and prediction of survival.
Blood Purif, 37 (2014), pp. 138-145
Z. Yilmaz, Y. Yildirim, F.Y. Aydin, E. Aydin, A.K. Kadiroglu, M.E. Yilmaz, et al.
Relationship between fluid status as assessed by bioimpedance analysis and NT-pro BNP, blood pressure and left ventricular mass index in hemodialysis patients.
Clin Ther, 165 (2014), pp. e52-e58
Copyright © 2014. SEDYT
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos